Jun. 23 at 8:44 PM
$MIST Patience is all that’s needed here. UHC’s approval greatly improves the odds Optum will approve as well. Once both PBMs approve (hopefully by the end of the year), the SP should hit
$4-
$6. China and/or EU this year would be a bonus. Once both PBMs are on board and if Medicare approves sometime in 2027, SP should be somewhere between
$6-
$8. The gasoline for this stock still remains to be Afib. Double digits SP depends on it. Or, IMHO, a BO if phase 3 looks promising.
